Talk:Levocetirizine

From Wikipedia, the free encyclopedia

	Levocetirizine is part of WikiProject Pharmacology, a project to improve all Pharmacology-related articles. If you would like to help improve this and other pharmacology articles, please join the project. All interested editors are welcome.
Start	This article has been rated as start-Class on the quality scale.
Mid	This article has been rated as mid-importance for this Project's importance scale.

This article was nominated for deletion on 23 Jun 2005. The result of the discussion was keep.

article has improved considerably, should therefore not be deleted rikXL 22:40, 23 Jun 2005 (UTC)

Third generation ??

Should this drug be genuinely considered as a third-generation antihistamine. In effect, it's only a minor derivative from the second-generation cetirizine, and nothing like the advance that cetirizine and other second-generation drugs were from the first-generation "sedating" antihistamines. My feeling is that to call it "third-generation" is unjustified hype.. and, as an aside, it's made very little impact on the marketplace.

SunnieBG 11:52, 26 October 2006 (UTC)

I don't think the article should be deleted, it contains in a nutshell what is really new about the drug.

I am gonna add an external link giving latest researh showing xyzal can actually prevent asthma attacks.

[edit] Structural formula

Structural formula given in the drugbox is that of an unspecified enantiomer of cetirizine; it can be used for racemic cetirizine, but not for levocetirizine, which is stereochemicaly the (R)-enantiomer (L-isomer); the correct structural formula is:
http://img132.imageshack.us/img132/7821/levocetirizinedv8.png
--84.163.87.66 10:48, 28 April 2007 (UTC)